Drug Development and Biologics in Asthma. A New Era.
Ann Am Thorac Soc
; 13 Suppl 1: S83-4, 2016 Mar.
Article
em En
| MEDLINE
| ID: mdl-27027958
ABSTRACT
Considerable progress has been made toward developing targeted biological therapeutics for asthma, due in large part to a deeper understanding of asthma pathophysiology. This explosion of knowledge has revealed asthma to be a much more complex and heterogeneous entity than previously understood. The identification of particular asthma phenotypes with distinct pathophysiologic mechanisms has opened up a new era for patient populations not well served by current therapies, especially patients with severe asthma.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Asma
/
Produtos Biológicos
/
Antiasmáticos
/
Descoberta de Drogas
Limite:
Animals
/
Humans
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article